| 1 |
30848363 | Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan. | 2019 Aug |
2 |
| 2 |
28815329 | Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study. | 2018 Apr |
2 |
| 3 |
26733671 | Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα. | 2017 Apr |
2 |
| 4 |
27890790 | Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B. | 2017 Mar |
2 |
| 5 |
25904097 | The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay. | 2016 Jan |
1 |
| 6 |
26440999 | Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b. | 2016 Mar |
1 |
| 7 |
27388424 | Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals. | 2016 Jul 7 |
1 |
| 8 |
27750228 | Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C. | 2016 |
2 |
| 9 |
25174254 | Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. | 2015 Jan |
1 |
| 10 |
25704315 | Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C. | 2015 Dec |
1 |
| 11 |
25764674 | [JSH guidelines for the management of hepatitis C virus infection (version 3)]. | 2015 Feb |
4 |